Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

CPIX Cumberland Pharmaceuticals Inc
$3.14 -4.94% -0.16
Notify me if price changes either direction
Interactive Brokers Logotype

Buy CPIX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 45.9M
Enterprise value 48.5M
Trailing PE -16.157894385488
Forward PE 23.428572
PEG Ratio 0.45242104279368
Enterprise to EBITDA 35.844
Enterprise to revenue 1.089
Price to book MRQ 1.9723392
Price to sales TTM 1.1018903

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-12-31
Revenue (TTM) 44.5M
EBITDA 3.0M
Diluted EPS TTM -0.19
Total Cash (MRQ) 11.4M
Current ratio (MRQ) 1.009
Operating Cash Flow (TTM) 4.9M

CPIX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent CPIX News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.